Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
SARS-CoV-2 causes a severe respiratory disease called COVID-19. Currently, global health
is facing its devastating outbreak. However, there is no vaccine available against this virus …
is facing its devastating outbreak. However, there is no vaccine available against this virus …
Immunoinformatics-based potential multi-peptide vaccine designing against Jamestown Canyon Virus (JCV) capable of eliciting cellular and humoral immune …
M Shahab, S Aiman, A Alshammari, AF Alasmari… - International Journal of …, 2023 - Elsevier
Jamestown Canyon virus (JCV) is a deadly viral infection transmitted by various mosquito
species. This mosquito-borne virus belongs to Bunyaviridae family, posing a high public …
species. This mosquito-borne virus belongs to Bunyaviridae family, posing a high public …
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
P Jaishwal, K Jha, SP Singh - International Journal of Biological …, 2024 - Elsevier
Even though the use of SARS-CoV-2 vaccines during the COVID-19 pandemic showed
unprecedented success in a short time, it also exposed a flaw in the current vaccine design …
unprecedented success in a short time, it also exposed a flaw in the current vaccine design …
Immunoinformatics-driven in silico vaccine design for Nipah virus (NPV): Integrating machine learning and computational epitope prediction
The Nipah virus (NPV) is a highly lethal virus, known for its significant fatality rate. The virus
initially originated in Malaysia in 1998 and later led to outbreaks in nearby countries such as …
initially originated in Malaysia in 1998 and later led to outbreaks in nearby countries such as …
A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria
Human malaria is a pathogenic disease mainly caused by Plasmodium falciparum, which
was responsible for about 405,000 deaths globally in the year 2018. To date, several …
was responsible for about 405,000 deaths globally in the year 2018. To date, several …
Immunoinformatics approach to design a novel subunit vaccine against visceral leishmaniasis
A Lari, N Lari, A Biabangard - International Journal of Peptide Research …, 2022 - Springer
Visceral leishmaniasis (VL) infection is mostly caused by Leishmania donovani and affects
countries worldwide. Despite the need for a safe and effective vaccine against leishmaniasis …
countries worldwide. Despite the need for a safe and effective vaccine against leishmaniasis …
Prediction of an immunogenic peptide ensemble and multi-subunit vaccine for Visceral leishmaniasis using bioinformatics approaches
Visceral Leishmaniasis (VL) is a neglected tropical disease of public health importance in
the Indian subcontinent. Despite consistent elimination initiatives, the disease has not yet …
the Indian subcontinent. Despite consistent elimination initiatives, the disease has not yet …
Computational design of candidate multi-epitope vaccine against SARS-CoV-2 targeting structural (S and N) and non-structural (NSP3 and NSP12) proteins
The COVID-19 pandemic caused by SARS-CoV-2 virus has created a global damage and
has exposed the vulnerable side of scientific research towards novel diseases. The intensity …
has exposed the vulnerable side of scientific research towards novel diseases. The intensity …
A structural vaccinology approach for in silico designing of a potential self-assembled nanovaccine against Leishmania infantum
B Vakili, N Nezafat, M Negahdaripour… - Experimental …, 2022 - Elsevier
Visceral leishmaniasis (VL) remains a major public health problem across 98 countries. To
date, VL has no effective drug. Vaccines, as the most successful breakthroughs in medicine …
date, VL has no effective drug. Vaccines, as the most successful breakthroughs in medicine …
Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis
Cutaneous leishmaniasis (CL) is one of the illnesses caused by Leishmania parasite
infection, which can be asymptomatic or severe according to the infecting Leishmania strain …
infection, which can be asymptomatic or severe according to the infecting Leishmania strain …